Imunon (IMNN): Chief Medical Officer received 13K units
Douglas Vincent Faller, Chief Medical Officer at Imunon, reported a grant / award of 13K units.
- 13K
- Derivative units
- Traded
- Jan 2, 2026
- Filed
- Jan 6, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 13, 2025Company filing · Form 8-K · ResultsReported its results
- Dec 29, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
What came next
- Jan 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 7, 2026, Imunon, Inc. (the “Company”) announced that Kimberly Graper, its interim Chief Financial Officer, will be resigning from her role effective January 14, 2026.”
- Feb 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 2, 2026, Khursheed Anwer informed Imunon, Inc. (the “Company”) of his intent to retire as Executive Vice President and Chief Scientific Officer from the Company, and Dr. Anwer’s employment with the Company will end, effective February 20, 2026 (the “Retirement Date”).”
- Mar 31, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Imunon
For Imunon, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMNN page.
How this filing works
Explore the data
Other disclosures at Imunon
- SEC Form 4Sep 1, 2026
- SEC Form 4Aug 17, 2026
- SEC Form 4Aug 4, 2026
- SEC Form 4Jul 21, 2026
- SEC Form 4Jul 7, 2026
- SEC Form 4Jun 29, 2026
Everything OQRO holds on this company is on its IMNN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data